Nyxoah SA (NYXH)
NGM · Healthcare · Medical Instruments & Supplies
$1.39
-6.71%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$138.9M
Shares Outstanding
99.9M
P/S (TTM)
9.1x
Exchange
NGM
Currency
USD
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 1.3M | 2.0M | 5.6M | 6.4M |
| Gross Profit | 850K | 1.2M | 3.6M | 3.6M |
| Operating Income | -19.9M | -24.2M | -18.3M | -20.5M |
| Net Income | -20.6M | -23.6M | -23.5M | -15.9M |
| Diluted EPS | $-0.55 | $-0.63 | $-0.59 | $-0.37 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 3.1M | 4.3M | 4.5M | 10.0M |
| Gross Profit | 1.9M | 2.7M | 3.0M | 6.3M |
| Operating Income | -32.5M | -45.1M | -58.8M | -82.9M |
| Net Income | -31.2M | -43.2M | -59.2M | -90.1M |
| Diluted EPS | $-1.21 | $-1.54 | $-1.81 | $-2.36 |